Chapter 1. RARE DISEASE GENETIC TESTING  MARKET – Scope & Methodology

1.1. Market Segmentation

1.2. Assumptions

1.3. Research Methodology

1.4. Primary Sources

1.5. Secondary Sources

Chapter 2. RARE DISEASE GENETIC TESTING  MARKET – Executive Summary

2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)

2.2. Key Trends & Insights  

2.3. COVID-19 Impact Analysis

      2.3.1. Impact during 2023 – 2030

      2.3.2. Impact on Supply – Demand

Chapter 3. RARE DISEASE GENETIC TESTING  MARKET – Competition Scenario

3.1. Market Share Analysis

3.2. Product Benchmarking

3.3. Competitive Strategy & Development Scenario

3.4. Competitive Pricing Analysis

3.5. Supplier - Distributor Analysis

Chapter 4. RARE DISEASE GENETIC TESTING  MARKET - Entry Scenario

4.1. Case Studies – Start-up/Thriving Companies

4.2. Regulatory Scenario - By Region

4.3 Customer Analysis

4.4. Porter's Five Force Model

       4.4.1. Bargaining Power of Suppliers

       4.4.2. Bargaining Powers of Customers

       4.4.3. Threat of New Entrants

       4.4.4. Rivalry among Existing Players

       4.4.5. Threat of Substitutes

Chapter 5. RARE DISEASE GENETIC TESTING  MARKET - Landscape

5.1. Value Chain Analysis – Key Stakeholders Impact Analysis

5.2. Market Drivers

5.3. Market Restraints/Challenges

5.4. Market Opportunities

Chapter 6. RARE DISEASE GENETIC TESTING  MARKET – By Disease Type

6.1. Neurological Disease

6.2. Immunological Disorders

6.3. Hematology Diseases

6.4. Endocrine & Metabolism Diseases

6.5. Cancer

6.6. Musculoskeletal Disorders

6.7. Cardiovascular Disorders (CVDs)

6.8. Dermatology Disease

6.9. Others

Chapter 7. RARE DISEASE GENETIC TESTING  MARKET – By Technology

7.1. Next-Generation Sequencing (NGS)

7.1.1. Whole Exome Sequencing

7.1.2. Whole Genome Sequencing

7.2. Array Technology

7.3. PCR-based Testing

7.4. FISH

7.5. Sanger Sequencing

7.6. Karyotyping

Chapter 8. RARE DISEASE GENETIC TESTING  MARKET – By Specialty

8.1. Molecular Genetic Tests

8.2. Chromosomal Genetic Tests

8.3. Biochemical Genetic Tests

Chapter 9. RARE DISEASE GENETIC TESTING  MARKET – By  End-Use

9.1 Research Laboratories & CROs

9.2. Hospitals & Clinics

9.3. Diagnostic Laboratories

Chapter 10. RARE DISEASE GENETIC TESTING  MARKET – By Region

10.1. North America

10.2. Europe

10.3.The Asia Pacific

10.4.Latin America

10.5. Middle-East and Africa

Chapter 11. RARE DISEASE GENETIC TESTING  MARKET– Company Profiles – (Overview, Product Portfolio, Financials, Developments)

11.1. Company 1

11.2. Company 2

11.3. Company 3

11.4. Company 4

11.5. Company 5

11.6. Company 6

11.7. Company 7

11.8. Company 8

11.9. Company 9

11.10. Company 10

Download Sample